BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3987044)

  • 1. Urinary glycosaminoglycans in aspartylglycosaminuria: evidence for disturbed proteoglycan metabolism.
    Näntö-Salonen K; Larjava H; Aalto M; Kivimäki T
    Clin Chim Acta; 1985 Mar; 146(2-3):111-8. PubMed ID: 3987044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of collagen in aspartylglycosaminuria: urinary excretion of hydroxyproline.
    Näntö-Salonen K; Autio S; Härö E; Kivimäki T; Koskela SL; Näntö V; Penttinen R
    J Inherit Metab Dis; 1984; 7(3):117-21. PubMed ID: 6438393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartylglycosaminuria: an inborn error of glycoprotein catabolism.
    Maury CP
    J Inherit Metab Dis; 1982; 5(4):192-6. PubMed ID: 6820440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbed metabolism of copper and zinc in aspartylglycosaminuria: possible involvement with connective tissue changes.
    Näntö-Salonen K; Halme T; Penttinen R; Langevelde FV; Vis RD; Alfthan G
    J Inherit Metab Dis; 1985; 8(4):212-8. PubMed ID: 3939546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal dermal proteoglycan in aspartylglycosaminuria: a possible mechanism for ultrastructural changes of collagen fibrils in a glycoprotein storage disorder.
    Näntö-Salonen K; Larjava H; Säämanen AM; Heino J; Penttinen R; Pelliniemi LJ; Tammi M
    Connect Tissue Res; 1987; 16(4):367-76. PubMed ID: 3132350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of collagen in aspartylglycosaminuria: decreased synthesis by cultured fibroblasts.
    Näntö-Salonen K; Penttinen R
    J Inherit Metab Dis; 1982; 5(4):197-203. PubMed ID: 6820441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Acetylglucosamine-asparagine levels in tissues of patients with aspartylglycosaminuria.
    Maury CP; Palo J
    Clin Chim Acta; 1980 Dec; 108(2):293-9. PubMed ID: 7449147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory detection of aspartylglycosaminuria.
    Mononen I; Kaartinen V; Mononen T
    Scand J Clin Lab Invest Suppl; 1988; 191():7-11. PubMed ID: 3247584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aspartylglycosaminuria by gas--liquid chromatography.
    Maury CP
    Clin Chem; 1981 Dec; 27(12):2058-60. PubMed ID: 7307258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID).
    Thompson JN; Jones MZ; Dawson G; Huffman PS
    J Inherit Metab Dis; 1992; 15(5):760-8. PubMed ID: 1434515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal collagen fibrils in aspartylglycosaminuria. Altered dermal ultrastructure in a glycoprotein storage disorder.
    Näntö-Salonen K; Pelliniemi LJ; Autio S; Kivimäki T; Rapola J; Penttinen R
    Lab Invest; 1984 Oct; 51(4):464-8. PubMed ID: 6592395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-chromatographic detection of aspartylglycosaminuria.
    Mononen T; Parviainen M; Penttilä I; Mononen I
    Clin Chem; 1986 Mar; 32(3):501-2. PubMed ID: 3948393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low urinary excretion of heparan sulfate in three patients with Lowe's syndrome.
    Yokoi T; Uozaki T; Kasei M; Sato T; Taniguchi N
    Clin Chim Acta; 1981 Oct; 116(2):153-60. PubMed ID: 6457705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of acid glycosaminoglycans and hydroxyproline in a patient with oculo-cerebro-renal syndrome.
    Hayashi S; Nagata T; Kimura A; Tsurumi K
    Tohoku J Exp Med; 1978 Nov; 126(3):215-23. PubMed ID: 734646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of 4-N-2-acetamido-2-deoxy-beta-D-glucopyranosyl-L-asparagine in the urine of patients with aspartylglycosaminuria by gas-liquid chromatography.
    Maury P
    J Lab Clin Med; 1979 May; 93(5):718-23. PubMed ID: 429870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compositional changes of urinary acidic glycosaminoglycans in progressive systemic sclerosis.
    Murata K; Takeda M
    Clin Chim Acta; 1980 Nov; 108(1):49-59. PubMed ID: 6778637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
    De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
    J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
    J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartylglycosaminuria diagnosed by routine urine amino acid assay.
    Rudy JL
    Clin Chem; 1988 Oct; 34(10):2164. PubMed ID: 3168251
    [No Abstract]   [Full Text] [Related]  

  • 20. Undersulfated urinary glycosaminoglycans in preterm newborns.
    Coppa GV; Gabrielli O; Maiorana A; Sani S; Benincasa A; Belsito M; Montali U
    Biol Neonate; 1978; 33(1-2):18-24. PubMed ID: 656519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.